secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbCellera Biologics Inc. (ABCL)
CIK:        0001703057
Form:       8-K
Filed at:   2025-02-18T23:59:59+00:00
Accession:  0001628280-25-005983
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

AbCellera COO Lecault transitions to CTO; COO role dissolved
------------------------------------------------------------

- Effective Feb 18, 2025, Veronique Lecault moved from COO to CTO.
- Change agreed mutually, not due to any disagreement with company.
- COO position will not be filled and is dissolved.
- Lecault remains a director on the Board of Directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703057/000162828025005983/0001628280-25-005983-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703057/000162828025005983/abcl-20250218.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-005983

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer